n-methyladenosine has been researched along with Liver Neoplasms in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (19.30) | 24.3611 |
| 2020's | 46 (80.70) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, M; Fang, L; Guo, RP; Li, SH; Mei, J; Wei, W; Zhao, RC; Zou, JW | 1 |
| Chen, A; Li, Y; Shao, J; Shen, M; Wang, Y; Yin, G; Zhang, F; Zhang, Z; Zheng, S | 1 |
| Lou, J; Ni, J; Shao, Y; Shi, C; Wei, S; Zhao, H; Zhou, Q | 1 |
| Lu, WJ; Yu, S; Zhu, HX; Zhu, WP | 1 |
| Cui, Z; Deng, L; Huang, N; Li, G; Ma, J; Pan, Q; Sun, F; Wu, Q | 1 |
| Cai, X; Chen, Y; Ge, J; Ling, Z; Lv, Z; Man, D; Wu, J; Xie, H; Xu, Y; Yu, C; Zhang, D; Zhang, Y; Zheng, S; Zhou, L | 1 |
| Chen, CW; Chen, J; Chen, Z; Deng, X; Dong, L; Gao, L; Gao, M; Han, L; He, C; He, PC; Horne, D; Huang, W; Li, C; Li, W; Li, Y; Liu, W; Nam, Y; Prince, E; Qin, H; Qin, X; Qing, Y; Rosen, ST; Shen, C; Su, R; Sun, M; Tan, B; Wei, J; Wu, X; Xue, J; Xue, M; Zhao, Z; Zhou, K | 1 |
| Cai, MY; Chen, RX; Chen, W; Deng, MH; Duan, JL; Han, K; Liang, H; Mei, J; Nie, RC; Teng, K; Wang, FW; Xiang, ZC; Xie, D; Xie, JJ; Yin, YX; Zhang, ML; Zhang, N | 1 |
| Mo, YY; Peng, WX | 1 |
| Ke, W; Lu, Z; Zhang, L; Zhao, X | 1 |
| Bian, Z; Cui, Z; Gu, S; He, J; Huang, N; Liu, L; Man, Q; Sun, F; Sun, G; Xu, C; Xu, W; Zhang, Y; Zhuang, C | 1 |
| Auld, FM; Leng, R; Sergi, CM; Shen, F | 1 |
| Cao, Y; Geng, C; He, G; Liu, S; Pan, H; Wu, S | 1 |
| Bai, M; Feng, Z; Fu, Y; Hua, Y; Ke, S; Li, X; Li, Z; Lu, S; Ma, Y; Pan, S; Qian, B; Wang, C; Xu, Y; Yin, B; Yu, H; Zhou, M; Zhou, Y | 1 |
| Chen, B; Guo, S; Han, H; Kuang, M; Lin, S; Ma, J; Peng, H; Peng, S; Wang, L; Wei, W; Yang, C | 1 |
| Chen, G; Chen, L; Cheng, H; Deng, T; Fan, Y; Gong, P; Niu, X; Tian, Y; Wang, P; Wang, W; Xiao, H; Yang, L; Yang, Y; Yuan, J; Zhang, J; Zhang, P; Zhang, W; Zhang, X | 1 |
| Feng, Z; Gao, Q; Hu, J; Huang, A; Huang, L; Tang, N; Wang, K; Yan, Y; Yang, Y; Yin, J | 1 |
| Cheng, ZJ; Huang, SY; Kawaguchi, T; Li, HF; Liang, B; Ni, JS; Samant, H; Tao, YP; Wang, ZG; Wu, J; Xiang, DM; Yang, L; Yang, Y; Yuan, SX; Zheng, H; Zhou, WP | 1 |
| Hu, J; Wang, Q; Xue, C | 1 |
| Liu, Y; Si, Z; Wang, X; Yu, L; Zhou, M | 1 |
| Feng, M; He, C; Hou, J; Hu, B; Huang, X; Liu, J; Lu, Z; Shen, B; Smyth, MJ; Sun, B; Wang, J; Xia, Q; Zhang, H; Zhao, Z; Zhou, J | 1 |
| Chen, X; Hao, X; Huang, J; Lan, T; Li, H; Li, J; Liao, H; Liao, M; Liu, H; Wu, H; Xie, K; Xu, L; Yan, X; Yuan, K; Zeng, Y; Zhang, D | 1 |
| Cai, J; Cao, M; Chen, Z; Gao, W; Wang, J; Wang, X; Wu, J; Zhang, Y; Zuo, X | 1 |
| Fang, J; Li, F; Li, Z; Peng, Y; Zhou, J | 1 |
| Cui, X; Fan, Y; Li, J; Ren, Z; Sun, R; Wang, Z; Zhang, D; Zhao, W; Zhu, J | 1 |
| Bo, X; Jiang, H; Liu, Z; Qin, S; Qu, N; Tan, C; Wen, G; Zhang, X | 1 |
| Chen, M; Wong, CM | 1 |
| Dai, C; Ding, H; Jia, C; Su, Y; Zhang, X | 1 |
| Bo, H; Cao, K; Chen, X; Gong, L; Guo, F; He, D; Li, R; Li, X; Liu, J; Liu, X; Wang, F; Wang, Q; Wang, X; Xiao, W; Xing, X; Xiong, W; Xu, C; Zeng, Q; Zhou, J; Zhou, M; Zhou, Y; Zhu, Y | 1 |
| He, X; Hou, B; Huang, K; Huang, S; Ji, F; Ma, Z; Ruan, S; Zhang, C; Zhou, Z; Zhuang, H | 1 |
| Bu, X; Chen, D; Chen, L; Chen, X; Cheng, C; He, W; Liang, H; Lin, Z; Niu, Y; Sun, L; Wan, A; Wan, G; Zhan, S; Zhang, X | 1 |
| Chen, P; Dai, X; Tao, L; Wu, X; Zhang, X | 1 |
| Chang, Z; Li, Z; Liu, Y; Lu, X; Luo, C; Qiao, K; Sun, T; Xu, Z; Yang, C; Zhang, C; Zhang, H | 1 |
| Chen, X; Gao, T; He, B; Li, C; Liu, X; Pan, B; Pan, Y; Qin, J; Sun, H; Wang, S; Xu, M; Xu, T; Xu, X; Zeng, K | 1 |
| Cai, X; Cen, D; Gorshkov, K; Ji, L; Jiang, S; Liang, X; Lin, Z; Mao, Q; Tang, M; Wan, Z; Xia, S; Xu, J; Zheng, J | 1 |
| Hayashi, M; Inokawa, Y; Kanda, M; Kandimalla, R; Kodera, Y; Koike, M; Nakagawa, N; Nakayama, G; Sonohara, F; Sunagawa, Y; Takami, H; Tanaka, C; Tanaka, K; Yamada, S | 1 |
| Han, F; Li, Q; Wang, T; Wang, Z; Yang, N; Zhou, J; Zhu, R | 1 |
| Huang, C; Li, J; Pan, XY | 1 |
| Arumugam, T; Chuturgoon, AA; Ghazi, T | 1 |
| Hu, Y; Jiang, R; Li, Q; Ni, Y; Pu, L; Qiu, J; Tang, J; Wang, X; Xu, J; Yang, H; Zhang, L | 1 |
| Liu, J; Wang, D; Wang, L; Yang, M; Zeng, J; Zhang, N; Zhou, J; Zhou, L | 1 |
| Yu, ZL; Zhu, ZM | 1 |
| Gao, W; Huang, H; Jin, L; Lin, J; Qu, S; Zeng, Z | 1 |
| Jiang, H; Lv, W; Ning, G; Wang, Y | 1 |
| Cai, J; Xu, J; Zhou, M | 1 |
| Chen, X; Jiang, J; Li, D; Wang, A; Yang, L | 1 |
| Chen, X; Mao, Y; Qin, S; Qin, Y; Xiao, J; Zhao, L | 1 |
| Bian, Z; Chen, Y; Du, L; Liu, Y; Pan, Q; Qian, Z; Sun, F; Wang, J; Wu, Q; Xu, W; Xu, Y; Yu, Y; Zhang, X; Zhang, Y; Zheng, W; Zhu, G | 1 |
| Bley, N; Chen, J; Dahl, A; Fuchs, T; Glaß, M; Haase, J; Huang, H; Hüttelmaier, S; Lederer, M; Müller, S; Posern, G; Singh, AK | 1 |
| Kang, T; Li, X; Liao, D; Ma, H; Zeng, C; Zhang, M; Zhang, R; Zhong, L | 1 |
| Cai, J; Chen, H; Chen, K; Dai, Q; Fan, J; He, C; Klaholz, BP; Lan, F; Lu, Z; Lv, R; Ma, H; Natchiar, SK; Pan, T; Shi, Y; Shi, YG; Wang, X | 1 |
| Hamada, M; Zhang, Y | 1 |
| An, P; Chen, F; Chen, Z; Du, J; Jiang, G; Li, J; Liu, H; Lu, L; Luo, N; Shan, H; Tian, L; Wang, H; Wu, Y; Yang, X | 1 |
| Chai, G; Chen, F; Du, J; He, C; Li, J; Lin, S; Lin, X; Liu, J; Luo, G; Tauler, J; Wang, H; Wu, Y | 1 |
| Liu, F; Ma, JZ; Sun, SH; Wang, F; Wang, TT; Xu, QG; Yang, F; Yuan, JH; Zhou, CC; Zhou, WP | 1 |
| Feng, G; Gao, S; Li, J; Li, Y; Liu, Y; Wang, Y; Yang, Z; Ye, L; Zhang, S; Zhang, X | 1 |
6 review(s) available for n-methyladenosine and Liver Neoplasms
| Article | Year |
|---|---|
The Role of N
Topics: Adenosine; Hepatoblastoma; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
N
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Melanoma; RNA; Tumor Microenvironment | 2023 |
The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
Topics: Adenosine; Animals; Biomarkers, Tumor; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; RNA Processing, Post-Transcriptional; RNA, Neoplasm | 2020 |
The emerging roles of m
Topics: Adenosine; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Chromosomal Instability; Hepatitis, Viral, Human; Humans; Lipid Metabolism; Liver Neoplasms; Molecular Targeted Therapy; Neovascularization, Pathologic | 2021 |
The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Prognosis; RNA, Circular | 2021 |
1 trial(s) available for n-methyladenosine and Liver Neoplasms
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
51 other study(ies) available for n-methyladenosine and Liver Neoplasms
| Article | Year |
|---|---|
Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cluster Analysis; Computational Biology; Databases, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Methylation; Prognosis; Protein Interaction Mapping; Protein Interaction Maps; RNA; ROC Curve; Transcriptome | 2021 |
N
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Autophagy; Carcinoma, Hepatocellular; Ferroptosis; Hepatic Stellate Cells; Humans; Liver Neoplasms; Mice; Retrospective Studies; Signal Transduction | 2021 |
RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Prognosis; RNA; Tumor Microenvironment | 2021 |
Comprehensive analysis of N
Topics: Adenosine; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Prognosis; Proportional Hazards Models; RNA, Long Noncoding; Tumor Microenvironment | 2021 |
m
Topics: Adenosine; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Liver Neoplasms; Phosphorylation; RNA Splicing Factors; Signal Transduction; Up-Regulation | 2021 |
Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Methylation; Middle Aged; Prognosis; RNA-Binding Proteins; RNA, Circular; YAP-Signaling Proteins | 2022 |
METTL16 exerts an m
Topics: Adenosine; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cytosol; Eukaryotic Initiation Factor-3; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Methyltransferases; Mice, Inbred NOD; Mice, SCID; Protein Biosynthesis; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Ribosomal; Signal Transduction; Tumor Burden | 2022 |
A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma.
Topics: Adenosine; Apoptosis; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Peptides | 2022 |
Connecting N6-methyladenosine modification to ferroptosis resistance in hepatoblastoma.
Topics: Adenosine; Ferroptosis; Hepatoblastoma; Humans; Liver Neoplasms | 2022 |
Resina Draconis extract exerts anti-HCC effects through METTL3-m6A-Survivin axis.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Methyltransferases; Mice; Mice, Nude; Plant Extracts; RNA, Messenger; Survivin | 2022 |
The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Topics: Adenosine; Amino Acid Transport System y+; Animals; Ferroptosis; Hepatoblastoma; Humans; Immediate-Early Proteins; Liver Neoplasms; Methyltransferases; RNA, Messenger; Tumor Suppressor Proteins | 2022 |
Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methylation; Nuclear Proteins; Prognosis; RNA; RNA-Binding Proteins | 2022 |
Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
Topics: Adenosine; Apolipoproteins; Biomarkers; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male | 2022 |
N
Topics: Adenosine; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Fatty Acids; Lipid Metabolism; Liver Neoplasms; Mice; RNA, Ribosomal, 18S | 2022 |
Crosstalk between 5-methylcytosine and N
Topics: 5-Methylcytosine; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; G2 Phase Cell Cycle Checkpoints; Humans; Liver Neoplasms; Pharmacogenetics | 2023 |
O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N
Topics: Carcinoma, Hepatocellular; Hepatitis B virus; Humans; Liver Neoplasms; RNA; RNA-Binding Proteins | 2023 |
N
Topics: Adenosine; Bone Neoplasms; Carcinoma, Hepatocellular; Carrier Proteins; Humans; Liver Neoplasms; Methyltransferases; Tumor Microenvironment | 2023 |
m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling.
Topics: Adenosine; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cell Line, Tumor; Colorectal Neoplasms; Dental Enamel Proteins; Humans; Liver Neoplasms; RNA-Binding Proteins; RNA, Antisense; Wnt Signaling Pathway | 2023 |
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Epigenesis, Genetic; Humans; Inflammation; Liver Neoplasms; Methylation; Mice; Models, Biological; Neovascularization, Pathologic; RNA-Binding Proteins; RNA, Messenger; Transcriptome | 2019 |
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Topics: Adenosine; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; GATA3 Transcription Factor; Humans; Liver Neoplasms; Methylation; Mice; Models, Biological; Neoplasm Metastasis; Prognosis; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Antisense; RNA, Long Noncoding; Xenograft Model Antitumor Assays | 2019 |
M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Lipogenesis; Liver Neoplasms; Mice, Inbred BALB C; Mice, SCID; RNA, Long Noncoding; Up-Regulation | 2020 |
Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
Topics: Adenosine; Biomarkers, Tumor; Carboxy-Lyases; Carcinoma, Hepatocellular; Cell Line, Tumor; Datasets as Topic; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Methylation; Methyltransferases; Nomograms; Risk Factors; RNA, Messenger; ROC Curve; Suppressor of Cytokine Signaling Proteins; Transaminases | 2020 |
Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Topics: Adenosine; Animals; Disease Progression; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Male; Methyltransferases; Mice, Inbred C57BL; Mice, Nude; MicroRNAs; Prognosis; Wnt Signaling Pathway | 2020 |
Multiple m
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease Progression; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Methyltransferases; Neoplasm Grading; Prognosis; RNA-Binding Proteins; Sequence Analysis, RNA | 2020 |
GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromogranins; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; GTP-Binding Protein alpha Subunits, Gs; Humans; Inflammation; Interleukin-6; Lipopolysaccharides; Liver Neoplasms; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; RNA Interference; RNA, Long Noncoding; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2020 |
SIRT1 Regulates N
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Computational Biology; Down-Regulation; Gene Expression Regulation, Neoplastic; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Liver Neoplasms; Male; Mice; Molecular Chaperones; Mutagenesis; Nuclear Pore Complex Proteins; Proteolysis; RNA Processing, Post-Transcriptional; RNA, Messenger; Sirtuin 1; Sumoylation; Xenograft Model Antitumor Assays | 2020 |
YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Octamer Transcription Factor-3; Prognosis; RNA-Binding Proteins; RNA, Messenger; Spheroids, Cellular; Transplantation, Heterologous; Tumor Cells, Cultured | 2020 |
RNA m
Topics: Adenosine; Animals; Autophagy; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Forkhead Box Protein O3; HEK293 Cells; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Male; Methylation; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; Sorafenib | 2020 |
Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Methylation; Prognosis; Reproducibility of Results; Risk Factors; RNA, Neoplasm | 2020 |
RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Silencing; Hippo Signaling Pathway; Humans; Liver Neoplasms; Methylation; Methyltransferases; Mice, Inbred BALB C; Mice, Nude; Molecular Mimicry; Prognosis; Protein Biosynthesis; Protein Serine-Threonine Kinases; RNA; RNA, Messenger; Signal Transduction; Transcription Factors; Xenograft Model Antitumor Assays; YAP-Signaling Proteins | 2021 |
Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Databases, Genetic; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Liver Neoplasms; Methylation; Methyltransferases; RNA Stability; RNA, Messenger; Signal Transduction; Transcriptome | 2020 |
N
Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; RNA, Circular; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinoma, Hepatocellular; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Methylation; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; RNA; Survival Analysis | 2020 |
HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Adult; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Methyltransferases; Models, Biological; Neoplasm Invasiveness; RNA, Messenger; Up-Regulation | 2021 |
Fumonisin B
Topics: Adenosine; Carcinoma, Hepatocellular; Epigenesis, Genetic; Fumonisins; Hep G2 Cells; Humans; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Methylation; NF-E2-Related Factor 2; Oxidative Stress; RNA; Signal Transduction | 2021 |
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
Topics: Adaptor Proteins, Vesicular Transport; Adenosine; Animals; Autophagy; Autophagy-Related Proteins; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Mice; RNA; RNA-Binding Proteins | 2021 |
N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Asian People; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Genotype; Humans; Liver Neoplasms; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; RNA Helicases; Treatment Outcome | 2021 |
Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Lymphocytes, Tumor-Infiltrating; Multivariate Analysis; Prognosis; Reproducibility of Results; RNA, Long Noncoding; Survival Analysis; Tumor Microenvironment | 2021 |
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Case-Control Studies; Feedback, Physiological; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Histones; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Prognosis; Promoter Regions, Genetic; RNA-Seq; Trans-Activators; Viral Regulatory and Accessory Proteins; Xenograft Model Antitumor Assays | 2021 |
Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Databases, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Male; Neoplasm Staging; Prognosis; Sorafenib; Treatment Outcome | 2021 |
N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Liver Neoplasms; Methylation; Prognosis; RNA; Tumor Microenvironment | 2021 |
METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis.
Topics: Adenosine; Apoptosis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Disease Progression; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Methyltransferases; Nerve Tissue Proteins; Prognosis; Survival Rate; Tumor Cells, Cultured | 2021 |
circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Adult; Aged; Animals; Biomarkers, Tumor; Carcinogenesis; Carcinoma, Hepatocellular; Cell Survival; Female; Hep G2 Cells; Hepatocyte Nuclear Factor 4; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Middle Aged; Promoter Regions, Genetic; Protein Interaction Domains and Motifs; RNA, Circular; ROC Curve; Transcription Factors; YAP-Signaling Proteins | 2018 |
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.
Topics: Adenosine; Animals; Cell Line, Tumor; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mice; MicroRNAs; Ovarian Neoplasms; RNA-Binding Proteins; Serum Response Factor; Xenograft Model Antitumor Assays | 2019 |
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma.
Topics: 3' Untranslated Regions; Adenosine; Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Tumor Burden; Tumor Hypoxia; Tumor Suppressor Proteins | 2019 |
N
Topics: Adenosine; Animals; Cell Proliferation; Humans; Liver Neoplasms; Male; Methylation; Methyltransferases; Mice, Inbred BALB C; Protein Biosynthesis; RNA, Ribosomal, 28S; Xenograft Model Antitumor Assays | 2019 |
DeepM6ASeq: prediction and characterization of m6A-containing sequences using deep learning.
Topics: Adenosine; Alternative Splicing; Animals; Brain; Carcinoma, Hepatocellular; Computational Biology; Deep Learning; Embryonic Stem Cells; Humans; Liver Neoplasms; Methylation; Mice; RNA; Sequence Analysis, RNA; Zebrafish | 2018 |
m
Topics: Adenosine; Animals; Base Sequence; Cell Line, Tumor; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; F-Box Proteins; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Nude; Neoplasm Staging; Nuclear Proteins; Nucleic Acid Conformation; RNA, Long Noncoding; Signal Transduction; Survival Analysis; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays; Zinc Finger E-box-Binding Homeobox 1 | 2019 |
RNA m
Topics: Adenosine; Animals; Cell Line, Tumor; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Methylation; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; RNA; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; Snail Family Transcription Factors; Tissue Array Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |
METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Methyltransferases; Mice; Mice, Inbred BALB C; MicroRNAs; Neoplasm Metastasis; RNA Interference; Sensitivity and Specificity; Signal Transduction; Survival Rate; Tumor Cells, Cultured | 2017 |
MicroRNA-145 Modulates
Topics: 3' Untranslated Regions; Adenosine; Carcinoma, Hepatocellular; Cell Proliferation; Down-Regulation; Hep G2 Cells; Humans; Immunohistochemistry; Liver Neoplasms; MicroRNAs; Microscopy, Fluorescence; Mutation; Plasmids; Protein Binding; Protein Domains; RNA-Binding Proteins; RNA, Small Interfering | 2017 |